中文产业新闻精选评分70Chinese source
罗氏IL-6抗体Vamikibart基于两项III期52周数据递交葡萄膜炎黄斑水肿上市申请
临床III期数据积极，罗氏IL-6抗体递交上市申请
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
临床III期数据积极，罗氏IL-6抗体递交上市申请
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.